Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Double Trouble": Ultra-Early Formation and Rupture of a De Novo Terminal Basilar Artery Aneurysm After Aneurysmal Subarachnoid Hemorrhage.

Vascular health and risk management·2026
Same author

Cerebrospinal fluid cfDNA-based molecular assessment of resection extent and prognosis in glioma.

Communications medicine·2026
Same author

Neutrophil Extracellular Trap Reprograms Cancer Metabolism to Form a Metastatic Niche Promoting Non-Small Cell Lung Cancer Brain Metastasis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

The role of systemic inflammation in the formation and rupture of intracranial aneurysms in moyamoya disease: a retrospective cohort study.

Annals of medicine·2025
Same author

Unraveling the Interplay Between Metabolism and Neurodevelopment in Health and Disease.

CNS neuroscience & therapeutics·2025
Same author

Filamin A in focus: unravelling the multifaceted roles of filamin A in neurodevelopment and neurological disorders.

Brain : a journal of neurology·2025

Related Experiment Video

Updated: Jan 13, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.1K

NAT10-mediated ac4C modifications regulate glioblastoma progression.

Li Lin1,2,3, Yu Xiong4, Yun Guo1,2,3

  • 1Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Cell Death & Disease
|January 8, 2026
PubMed
Summary

N-acetyltransferase 10 (NAT10) drives glioblastoma (GBM) progression by modifying BOC mRNA. Targeting NAT10 offers a potential therapeutic strategy for GBM, especially under hypoxic conditions.

More Related Videos

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.7K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.4K

Related Experiment Videos

Last Updated: Jan 13, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.1K
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.7K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.4K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • N4-acetylcytidine (ac4C) is an mRNA modification catalyzed by N-acetyltransferase 10 (NAT10).
  • The role of NAT10-mediated ac4C modification in glioblastoma (GBM) is not well understood.

Purpose of the Study:

  • To investigate the regulatory pathways and functional significance of NAT10 and ac4C in GBM.
  • To identify the targets and mechanisms of NAT10 action in GBM progression.

Main Methods:

  • Analysis of NAT10 expression in GBM patient data.
  • In vitro and in vivo functional assays to assess NAT10's role in GBM.
  • Identification of direct mRNA targets of NAT10 using molecular biology techniques.
  • Investigation of the regulatory interaction between HIF1α and NAT10.

Main Results:

  • NAT10 is upregulated in GBM and correlates with poor prognosis.
  • NAT10 promotes GBM cell proliferation, migration, and tumor growth.
  • BOC mRNA is a direct target of NAT10, with ac4C modification enhancing its stability and translation.
  • HIF1α transcriptionally activates NAT10, increasing BOC mRNA ac4C modification under hypoxia.
  • Pharmacological inhibition of NAT10 suppresses GBM growth, particularly under hypoxia.

Conclusions:

  • NAT10-mediated ac4C modification plays a crucial role in GBM oncogenesis.
  • NAT10 is a potential therapeutic target for GBM treatment, especially in hypoxic tumors.